Cellmid patents hair growth factor technology
Australian biotechnology company Cellmid has registered a patent with IP Australia for midkine as a treatment for hair loss and an enhancement for hair growth.
News & Analysis on Cosmetics Innovation
Australian biotechnology company Cellmid has registered a patent with IP Australia for midkine as a treatment for hair loss and an enhancement for hair growth.
'Manopause' refers to the declining testosterone levels in men from early middle age, resulting in lower energy and reduced strength and endurance. A segment personal care brands can tap into by addressing appearance issues.
Datamonitor Comment
In 2014, skin care companies turned to the 'DNA approach' in providing tailored supplements in Japan.
A new study reports little or no benefits from the nutrient addition in functional beverages, many of which are marketed with beauty from within claims.
Although included in Korea’s Ministry of Agriculture, Food and Rural Affairs (MAFRA) draft five year plan to phase out of animal testing for finished cosmetic products and ingredients, there is still some way to go as nothing has yet been finalised, with...